Технескан Сестамиби

Технескан Сестамиби is a radiopharmaceutical used in diagnostic imaging to evaluate heart function and detect coronary artery disease. This EU-originated product is administered intravenously for nuclear medicine scans. Short version: diagnostic imaging agent for heart function evaluation via nuclear medicine scans.

Технескан Сестамиби is primarily used as a diagnostic imaging agent in nuclear cardiology. It helps healthcare providers assess blood flow to the heart muscle and identify areas of reduced perfusion, often used in conjunction with stress tests. The product is also utilized in myocardial perfusion imaging to evaluate coronary artery disease and guide treatment decisions.

Following intravenous administration, Технескан Сестамиби distributes throughout the body, concentrating in areas with high blood flow, such as the heart muscle. The radiopharmaceutical emits gamma rays, which are detected by a gamma camera to create detailed images of organ function. Patients may experience mild discomfort at the injection site.

As a radiopharmaceutical, Технескан Сестамиби should only be handled and administered by trained healthcare professionals in a controlled clinical setting. Pregnant or breastfeeding individuals should inform their healthcare provider before use due to potential radiation exposure. Patients should follow all preparation instructions provided by their medical team.

No significant drug-drug interactions have been reported with Технескан Сестамиби. However, patients should disclose all medications, supplements, and medical conditions to their healthcare provider prior to administration. Certain medications, such as caffeine or nitrates, may affect test results and should be avoided as directed by a physician.